CLEC9A Mouse

These mice may be useful for studying adaptive immune responses to antigens in apoptotic and necrotic cells and for tracking DNGR-1+ dendritic cells. KO mouse strain

Contributors

Inventor Institute
Caetano Reis e Sousa Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Cat. #: 151613
Research Fields: Apoptosis and autophagy;Genetics;Immunology;Stem cell biology
Target: DNGR1
Zygosity: Homozygous
Phenotype: KO mice have a deficiency in the ability to cross present dead-cell associated antigens
Product description: These mice may be useful for studying adaptive immune responses to antigens in apoptotic and necrotic cells and for tracking DNGR-1+ dendritic cells. KO mouse strain
Conditional: No
Genetic background: Red/ET recombineering (Gene Bridges, Heidelberg, Germany) was used to capture the Clec9a region from BAC clone RP-23 248-K14 (C57BL/6 BAC clone from Invitrogen) into a conventional gene-targeting replacement vector, pFloxRI+tk. Primers included 20 nucleotides pairing with the vector and 70 nucleotides pairing with the desired regions of clec9a. Once the genomic region was captured into the Amp-resistant vector, a cassette including farnesylated EGFP, and the PGK-gb2 promoter followed by Kan/Neo was used and the recombineering homologous recombination step was repeated followed by selection for Kan. EGFP is inserted immediately downstream and in frame with the first two aminoacids from DNGR-1 and disrupts exons 1 and 2, knocking out a region of 1.35 Kb. Transcription is terminated by a strong poly A signal from EGFP. The targeting vector was linearized using Not I prior to transfection into S6B6 hybrid 129S6/C57BL/6 F1 derived embryonic stem (ES) cells by electroporation. Recombinant clones were isolated after culture in G418 and gancyclovir and were screened by PCR using two independent primer pairs with the forward primer in the Neo region and the reverse primer external to the short arm. Correctly targeted, karyotypically euploid ES clones were micro-injected into 3.5 day post coitum C57BL/6 blastocysts and resulting offspring with coat-color chimerism were bred with C57BL/6 females to identify germline transmission. Germline transmitting chimeras were subsequently bred with C57BL/6 females. (The expression of NK1.1 was linked to DNGR-1 deficiency in the clec9agfp mice indicating that the homologous recombination step targeted the chromosome of C57BL/6 origin in the F1 S6B6 ES cells; the use of the congenic (Cg) description in the strain name reflects this fact). Mutant mice were crossed with C57BL/6J for 1 more generation before being crossed with PGK-cre mice [ Tg(Pgk-cre)1Lni on a C57BL/6J congenic background ] to remove the neo selection cassette. These Clec9agfp mice were subsequently bred to C57BL/6J mice for at least a further 7 generations and were then interbred to generate the homozygous deficient B6(Cg)-Clec9atm1.1Crs animals.
Production details: Red/ET recombineering (Gene Bridges, Heidelberg, Germany) was used to capture the Clec9a region from BAC clone RP-23 248-K14 (C57BL/6 BAC clone from Invitrogen) into a conventional gene-targeting replacement vector, pFloxRI+tk. Primers included 20 nucleotides pairing with the vector and 70 nucleotides pairing with the desired regions of clec9a. Once the genomic region was captured into the Amp-resistant vector, a cassette including farnesylated EGFP, and the PGK-gb2 promoter followed by Kan/Neo was used and the recombineering homologous recombination step was repeated followed by selection for Kan. EGFP is inserted immediately downstream and in frame with the first two aminoacids from DNGR-1 and disrupts exons 1 and 2, knocking out a region of 1.35 Kb. Transcription is terminated by a strong poly A signal from EGFP. The targeting vector was linearized using Not I prior to transfection into S6B6 hybrid 129S6/C57BL/6 F1 derived embryonic stem (ES) cells by electroporation. Recombinant clones were isolated after culture in G418 and gancyclovir and were screened by PCR using two independent primer pairs with the forward primer in the Neo region and the reverse primer external to the short arm. Correctly targeted, karyotypically euploid ES clones were micro-injected into 3.5 day post coitum C57BL/6 blastocysts and resulting offspring with coat-color chimerism were bred with C57BL/6 females to identify germline transmission. Germline transmitting chimeras were subsequently bred with C57BL/6 females. (The expression of NK1.1 was linked to DNGR-1 deficiency in the clec9agfp mice indicating that the homologous recombination step targeted the chromosome of C57BL/6 origin in the F1 S6B6 ES cells; the use of the congenic (Cg) description in the strain name reflects this fact). Mutant mice were crossed with C57BL/6J for 1 more generation before being crossed with PGK-cre mice [ Tg(Pgk-cre)1Lni on a C57BL/6J congenic background ] to remove the neo selection cassette. These Clec9agfp mice were subsequently bred to C57BL/6J mice for at least a further 7 generations and were then interbred to generate the homozygous deficient B6(Cg)-Clec9atm1.1Crs animals.
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Schraml et al. 2013. Cell. 154(4):843-58. PMID: 23953115.

Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage.

Poulin et al. 2012. Blood. 119(25):6052-62. PMID: 22442345.

DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues.

Sancho et al. 2009. Nature. 458(7240):899-903. PMID: 19219027.

Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.

Related Tools for Mouse models

Cat. # Tool Name
151556 UNG Mouse Key Info View Tool
151444 InvEE Mouse Key Info View Tool
151454 Bmx Cre ERT2 Mouse Key Info View Tool
151550 Integrin a6b4 Mouse Key Info View Tool
151554 SAP1 Mouse Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.